| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0098 | 0.9 |